178 related articles for article (PubMed ID: 11548299)
1. Drifting agenda for federal treatment research.
Huff B
GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299
[No Abstract] [Full Text] [Related]
2. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
3. Four new antiretroviral medications will soon offer more options to HIV patients.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(4):1-3. PubMed ID: 11365545
[TBL] [Abstract][Full Text] [Related]
4. Antivirals update.
Proj Inf Perspect; 1998 Dec; (26):8-10. PubMed ID: 11366501
[TBL] [Abstract][Full Text] [Related]
5. New treatment options.
Fornataro K; Jefferys R
Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
[TBL] [Abstract][Full Text] [Related]
6. The medical merry-go-round: drugs for 1998 are new but not novel.
Gilden D
GMHC Treat Issues; 1997-1998 Winter; 12(1):18-25. PubMed ID: 11364984
[TBL] [Abstract][Full Text] [Related]
7. New drugs: amprenavir and abacavir.
TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
[TBL] [Abstract][Full Text] [Related]
8. Salvage therapy studies.
Proj Inf Perspect; 1998 Sep; (25):7. PubMed ID: 11365850
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report on 1592.
AIDS Clin Care; 1997 Sep; 9(9):71. PubMed ID: 11364756
[TBL] [Abstract][Full Text] [Related]
10. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
11. Trials for protease failure.
Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
[TBL] [Abstract][Full Text] [Related]
12. Amprenavir study results released.
AIDS Patient Care STDS; 1999 Dec; 13(12):754. PubMed ID: 10743545
[No Abstract] [Full Text] [Related]
13. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
Follansbee S; Deeks S; Bartnoff H
Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor combos.
Newsline People AIDS Coalit N Y; 1998 Feb; ():36-7. PubMed ID: 11367448
[TBL] [Abstract][Full Text] [Related]
16. Phase III results presented on amprenavir triple combination.
AIDS Patient Care STDS; 1998 Dec; 12(12):941-2. PubMed ID: 11362070
[No Abstract] [Full Text] [Related]
17. [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r].
MMW Fortschr Med; 2003 Dec; 145(50):61. PubMed ID: 14963981
[No Abstract] [Full Text] [Related]
18. Amping amprenavir with ritonavir.
TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
[No Abstract] [Full Text] [Related]
19. Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
Rizzardi GP; De Boer RJ; Hoover S; Tambussi G; Chapuis A; Halkic N; Bart PA; Miller V; Staszewski S; Notermans DW; Perrin L; Fox CH; Lange JM; Lazzarin A; Pantaleo G
J Clin Invest; 2000 Mar; 105(6):777-82. PubMed ID: 10727446
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches for the treatment of HIV.
Arroyo HT
Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
